AR Life Science
Hyderabad, India· Est.
Indian API manufacturer delivering GMP‑certified small‑molecule intermediates for global pharma.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
AI Company Overview
Indian API manufacturer delivering GMP‑certified small‑molecule intermediates for global pharma.
CardiovascularOncologyDiabetesUrologyPsychiatryAnti-coagulant
Technology Platform
GMP‑certified bulk synthesis of small‑molecule intermediates and APIs, supported by in‑house analytical R&D and FDA‑approved manufacturing capabilities.
Opportunities
Expanding capacity and obtaining additional regulatory approvals (e.g., EMA) can broaden export markets, while filing secondary DMFs accelerates customer product timelines.
Risk Factors
Intense competition from larger Indian API manufacturers and potential regulatory scrutiny could pressure margins and limit market share.
Competitive Landscape
AR Life Sciences competes with firms such as Sun Pharma, Aurobindo, and Divi's Laboratories, differentiating through FDA‑approved status for intermediates and a diversified therapeutic portfolio.